Reinsurance Group of America, Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGA research report →
Range $236 – $295
Price Chart
About the company
Reinsurance Group of America, Inc. (RGA) primarily operates within the reinsurance sector. The company delivers a comprehensive portfolio of life and health reinsurance products, spanning both individual and group coverages.
- CEO
- Tony Cheng
- IPO
- 2008
- Employees
- 4,300
- HQ
- Chesterfield, MO, US
Get TickerSpark's AI analysis on RGA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.35B
- P/E
- 10.20
- Fwd P/E
- 8.57
- PEG
- 0.10
- P/S
- 0.64
- P/B
- 1.49
- EV/EBITDA
- 7.00
- Div Yield
- 1.43%
- Gross Margin
- 27.26%
- Op Margin
- 8.43%
- Net Margin
- 6.34%
- ROE
- 13.15%
- ROIC
- 1.16%
Latest fiscal year · YoY change
- Revenue
- $22.79B+3.4%
- Gross Profit
- $5.79B+132.6%
- Op Income
- $1.54B
- Net Income
- $1.18B+64.9%
- EPS
- $17.94+64.6%
- OCF Growth
- -56.3%
- FCF Growth
- -56.3%
- 52W High
- $277.15
- 52W Low
- $184.78
- 50D MA
- $259.10
- 200D MA
- $229.64
- Beta
- 0.43
- RSI (14)
- 52
- Avg Volume
- 411.13K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
RGA delivered a strong third quarter with $736 million of pretax adjusted operating income, robust investment results, favorable claims experience, and continued capital deployment into attractive business.· November 6, 2026
- Pretax adjusted operating income was $736 million, or $8.49 per share after tax, with a trailing 12-month adjusted operating ROE of 19.1% excluding AOCI and notable items.
- Investment performance was a major driver: the core portfolio yield was 4.96% and the new money rate was 6.31%, while VII annualized returns were about 15% in the quarter.
- Claims were better than expected economically by $67 million, and the annual actuarial assumption review had no net impact on consolidated pretax adjusted operating income.
- RGA deployed $119 million into in-force transactions, returned $139 million to shareholders, and ended with about $1.8 billion of excess capital.
- Management said the pipeline remains healthy across the U.S. PRT, U.K. longevity, EMEA, and APAC, and confirmed Ruby Re capital was fully deployed.
RGA reported pretax adjusted operating income of $736 million for the quarter, or $8.49 per share after tax. Trailing 12-month adjusted operating ROE was 19.1% excluding AOCI and notable items. The core portfolio yield, excluding VII, was 4.96%, and the new money rate was 6.31%. Annualized VII returns were approximately 15% for the quarter and approximately 12% year to date. Economic claims were $67 million better than expectations, while the financial impact was a negative $9 million. The annual assumption review had no net impact on consolidated pretax adjusted operating income. Total premiums excluding PRT year to date grew 8.9%, or 8.2% constant currency. Guidance-wise, management said full-year 2026 VII returns are expected to fall within long-term expectations, and the annual assumption review should have a de minimis impact on the go-forward earnings run rate. Management continued to target a 20% to 30% payout ratio over the intermediate term and reiterated confidence in meeting or exceeding intermediate-term financial targets.
Tony Cheng framed the quarter as evidence that RGA’s strategy is working, citing deep biometric expertise, strong asset management, a global platform, and disciplined capital deployment. He emphasized broad strength across regions, including a pickup in U.S. PRT and U.K. longevity, strong APAC momentum, and exclusive transactions with attractive risk-adjusted returns. His tone was confident and strategic, with repeated references to durable advantages, a healthy pipeline, and confidence in 2026 and beyond.
Laura Cockrill highlighted that the quarter’s strength came from excellent variable investment income, strong new money rates, favorable in-force actions, and broad-based regional performance. She said the annual assumption review had no net impact on pretax adjusted operating income and is expected to have a de minimis effect on future run rate, while economic claims since 2023 have run favorable by over $400 million. She also noted $119 million deployed into in-force transactions, $139 million returned to shareholders, about $1.8 billion of excess capital, a 24.1% effective tax rate, and buybacks totaling $175 million year to date.
Analysts pressed on in-force actions, APAC growth, organic growth capital needs, Ruby Re’s next steps, group disability volatility, and the accounting treatment of favorable biometric experience. Management said the $57 million in-force action impact this quarter was entirely in uncapped cohorts, with an approximate $10 million to $15 million increase to the ongoing run rate from recent quarters; they also said the business remains active but timing is hard to predict. On APAC, management pointed to Japan’s regulatory tailwinds and Hong Kong product/underwriting capabilities, while on future sidecar launches they said they had no comment beyond keeping third-party capital a priority.
The call showed strong earnings power from a mix of investment income, favorable claims, and in-force actions, with no net hit from the annual assumption review. Management sounded confident about the pipeline, saying opportunities remain attractive across regions and that the company is well positioned to continue meeting or exceeding targets.
RGA noted that Q4 VII returns may not repeat the very strong quarter, and the effective tax rate came in modestly above the expected range. Management also acknowledged that in-force action timing is difficult to predict, and that some business lines like medical excess are being exited, which will reduce that revenue stream over time.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.7%
- Shares Outstanding
- 65.05M
- Float Shares
- 64.84M
of shares held by institutions
641 13F filers
Buy/sell ratio 0.42. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for RGA, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 6.94M | ▼ 136.00K |
| Blackrock, Inc. | 6.77M | ▼ 40.93K |
| Fmr LLC | 5.90M | ▼ 19.11K |
| Harris Associates L P | 4.68M | ▼ 166.05K |
| Vanguard Portfolio Management LLC | 3.47M | ▼ 19.17K |
| Wcm Investment Management, LLC | 3.26M | ▲ 250.72K |
| Vanguard Capital Management LLC | 2.93M | ▼ 34.66K |
| State Street Corp | 2.36M | ▲ 2.88K |
| Earnest Partners LLC | 2.10M | ▼ 116.87K |
| Geode Capital Management, LLC | 1.39M | ▼ 22.56K |
| Aqr Capital Management LLC | 1.34M | ▼ 524.10K |
| Dimensional Fund Advisors LP | 1.23M | ▲ 61.52K |
Held by 653 ETFs
Biggest fund positions in RGA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 18, 26 | HERRMANN RONALD | other | 54 |
| Nov 18, 26 | HERRMANN RONALD | other | 54 |
| Nov 18, 26 | HERRMANN RONALD | other | 54 |
| Nov 18, 26 | Hayden John W. | other | 10 |
| Nov 18, 26 | Hayden John W. | other | 10 |
| Nov 18, 26 | Hayden John W. | other | 10 |
| Nov 10, 26 | CHENG TONY KIN SHUN | other | 3,280 |
| Nov 10, 26 | CHENG TONY KIN SHUN | other | 1,553 |
| Nov 10, 26 | CHENG TONY KIN SHUN | other | 3,280 |
| Nov 10, 26 | Ozeki Arthur | other | 1,401 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RGA coverage
Recent articles, reports, and earnings notes.
No research on RGA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGA report →5 Life Insurance Stocks to Watch Amid Rising Private Credit Risks
zacks.com · Nov 20
What Makes Reinsurance Group (RGA) a Strong Momentum Stock: Buy Now?
zacks.com · Nov 17
Why Reinsurance Group (RGA) is a Top Momentum Stock for the Long-Term
zacks.com · Nov 17
Is Reinsurance Group of America (RGA) Stock Undervalued Right Now?
zacks.com · Nov 16
Reinsurance Group of America, Incorporated $RGA Shares Sold by Fifth Third Bancorp
defenseworld.net · Nov 15
2,330 Shares in Reinsurance Group of America, Incorporated $RGA Purchased by Alps Advisors Inc.
defenseworld.net · Nov 14
Reinsurance Group of America, Incorporated $RGA Shares Acquired by Ethic Inc.
defenseworld.net · Nov 12
What Reinsurance Group of America (RGA) Said on Its Q3 Earnings Call
marketbeat.com · Nov 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.